Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcatheter Aortic Valve Implantation With Myval THV (OCTACOR/OCTAPRO) in Patients With a Failing Successfully Im-planted First Transcatheter Heart Valve

NCT07215143 is registered in ClinicalTrials.gov with IHF GmbH - Institut für Herzinfarktforschung as lead sponsor.

NCT NCT07215143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07215143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcatheter Aortic Valve Implantation With Myval THV (OCTACOR/OCTAPRO) in Patients With a Failing Successfully Im-planted First Transcatheter Heart Valve
Lead sponsor
IHF GmbH - Institut für Herzinfarktforschung
Phase
Observational
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
June 30, 2033
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve stenosis